Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
129,929,313
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
84,121,058
-
Shares change
-
+4,578,082
-
Total reported value, excl. options
-
$3,152,798,116
-
Value change
-
+$159,886,756
-
Put/Call ratio
-
59%
-
Number of buys
-
92
-
Number of sells
-
92
-
Price
-
$37.48
Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q1 2023
231 filings reported holding PCVX - Vaxcyte, Inc. - COMMON STOCK as of 31 Mar 2023.
Vaxcyte, Inc. - COMMON STOCK (PCVX) had 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 84,121,058 shares of stock of the company.
Largest 10 holders included FMR LLC, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Capital Research Global Investors, Carlyle Group Inc., and Medicxi Ventures Management (Jersey) Ltd.
This table shows the top 186 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.